Recombinant fowlpox vaccine for protection against Marek's disease
US5369025A · kind A · utility
9Cited by
1References
1Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 10, 1991 |
| Grant date | Nov 29, 1994 |
| Priority date | — |
| Expiry date | Dec 10, 2011 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/948
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A recombinant fowlpox virus is disclosed which is useful as a vaccine for protection against Marek's Disease. The recombinant virus preferably contains a gene for one or more Marek's Disease Virus antigens such as glycoprotein B homologue, glycoprotein C homologue, glycoprotein D homologue, glycoprotein H homologue and tegument proteins, under the control of a poxvirus promoter within a region of the DNA of fowlpox virus which is not essential for virus growth.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.